SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-160159
Filing Date
2012-04-12
Accepted
2012-04-12 12:00:10
Documents
14
Period of Report
2012-05-23
Effectiveness Date
2012-04-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d294778ddef14a.htm DEF 14A 1371735
2 GRAPHIC g294778amgen_letterhead.jpg GRAPHIC 21059
3 GRAPHIC g294778david_scott.jpg GRAPHIC 8476
4 GRAPHIC g294778g10q39.jpg GRAPHIC 36241
5 GRAPHIC g294778g11g19.jpg GRAPHIC 12238
6 GRAPHIC g294778g16e64.jpg GRAPHIC 11257
7 GRAPHIC g294778g17x52.jpg GRAPHIC 24797
8 GRAPHIC g294778g38n85.jpg GRAPHIC 44581
9 GRAPHIC g294778g48f15.jpg GRAPHIC 13423
10 GRAPHIC g294778kevin_sharer.jpg GRAPHIC 6560
11 GRAPHIC g294778letterhead_002.jpg GRAPHIC 16940
12 GRAPHIC g294778pc1.jpg GRAPHIC 167979
13 GRAPHIC g294778pc3.jpg GRAPHIC 161060
14 GRAPHIC g294778recycle_symbol.jpg GRAPHIC 2556
  Complete submission text file 0001193125-12-160159.txt   2101180
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-12477 | Film No.: 12755847
SIC: 2836 Biological Products, (No Diagnostic Substances)